Abstract
The influence of tetrodotoxin (TTX) and calcium on the increase of extracellular dopamine (DA) levels in the nucleus accumbens (NAcc), evoked by the systemic administration of nicotine, cocaine andd-amphetamine, have been studied in conscious, freely moving rats using in vivo microdialysis. TTX (10−6 M), administered via the dialysis probe, completely abolished (P<0.01) the elevations in extracellular DA, DOPAC and HVA seen following nicotine (0.4 mg/kg SC). The removal of calcium with the inclusion of diaminoethanete-traacetic acid (EDTA 10−4 M) in the Ringer solution was also associated with inhibition (P<0.01) of the nicotine-induced changes in these parameters. The systemic administration of cocaine (15 mg/kg IP) andd-amphetamine (0.5 mg/kg SC) caused elevations in extracellular DA (P<0.01) accompanied by significant decreases (P<0.01) in HVA levels. DOPAC levels were also significantly (P<0.01) lowered byd-amphetamine treatment. The presence of TTX and removal of calcium with addition of EDTA completely abolished the changes in NAcc DA and HVA induced by cocaine. TTX had no influence on thed-amphetamine evoked responses in NAcc DA. However, the metabolites, which were markedly reduced by the TTX, were not further decreased by the systemic administration ofd-amphetamine. NAcc DA was significantly (P<0.01) raised followingd-amphetamine in the absence of calcium and presence of EDTA. However, this was significantly (P<0.01) attenuated in comparison to that seen in the presence of calcium. The results support the conclusion that, at the dose tested, nicotine evokes increases in extracellular NAcc DA levels by calcium and impulse-dependent mechanisms. Moreover, the data are also consistent with a partial calcium-dependent component ind-amphetamine-induced stimulation of this system in vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Balfour DJK, Gerrard L (1991) Attenuation of locomotor stimulant responses to nicotine and amphetamine by selective dopamine receptor antagonists. Br J Pharmacol 104:265 p
Benwell MEM, Balfour DJK (1992) The effect of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849–856
Benwell MEM, Balfour DJK Lucchi HM (1991) The influence of calcium on extracellular dopamine levels in the nucleus accumbens. Br J Pharmacol 104:59
Carboni E, Imperato A, Perezzani L, Di Chiara G (1989) Amphetamine, cocaine phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely-moving rats. Neuroscience 28:653–661
Clarke PBS (1990) Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem Pharmacol 40:1427–1432
Clarke PBS, Pert A (1985) Autoradiographic evidence for nicotinic receptors on nigrostriatal and mesolimbic dopaminergic neurones. Brain Res 348:355–358
Clarke PBS, Fu DS, Jakubovic A, Fibiger HC (1988) Evidence that mesolimbic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther 246:701–708
Corrigall WA, Coen KM (1991) Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104:171–176
Corrigall WA, Franklin KBJ, Coen KM, Clarke PBS (1992) The mesolimbic dopamine system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107:285–289
Damsma G, Day J, Fibiger HC (1989) Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol 168:363–368
Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278
Giorgieff-Chesselet MF, Kemel ML, Wandscheer D, Glowinski J (1979) Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effects of nicotine in a low concentration. Life Sci 25:1257–1262
Heikkila RE, Orlansky H, Cohen G (1975) Studies on the distinction between uptake, inhibition and release of [3H] dopamine in rat brain slices. Biochem Pharmacol 27:1063–1068
Imperato A, Mulas A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337–338
Izenwasser S, Jacocks HM, Rosenberger, JC, Cox BM (1991) Nicotine indirectly inhibits [3H] dopamine uptake at concentrations which do not directly promote [3H] dopamine release in the rat striatum. J Neurochem 56:603–610
Jacokks HM, Cox BM (1992) Serotonin-stimulated blease of [3H] dopamine via bretsal of the dopamine transporter in Rat striatum and nucleus accumbens: a comparison with blease elicited by potassium, N-Methyl-d-aspartic acid, glutamic acid and d-amphetamine. J Pharmacol Exptl therap 262:356–364
Kalivas PW, Duffy P (1990) Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5:48–58
Kuscenski R (1983) Biochemical actions of amphetamine and other stimulants. In: Creese I (ed.) Central nervous system pharmacology: stimulants: neurochemical, behavioural and clinical perspectives. Raven, New York. pp 31–61
Mereu M, Yoon W-K P, Boi V, Gessa GL, Naes L, Westfall TC (1987) Preferential stimulation of ventral tegmental area dopaminergic neurones by nicotine. Eur J Pharmacol 141:395–399
Mifsud JC, Hernandez L, Hoebel BG (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365–367
Museo E, Wise RA (1990a) Locomotion induced by ventral tegmental microinjections of a nicotinic agonist. Pharmacol Biochem Behav 35:735–737
Museo E, Wise RA (1990b) Microinjections of a nicotinic agonist into dopamine terminal fields: effects on locomotion. Pharmacol Biochem Behav 37:113–116
Naharashi T (1974) Chemical tools in the study of excitable membranes. Physiol Rev 54:813–889
Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1990) In vivo characterisation of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6:106–112
O'Neill MF, Dourish CT, Iversen SD (1991) Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity. Psychopharmacology 104:343–350
Rapier C, Lunt GG, Wonnacott S (1990) Nicotinic modulation of dopamine release from striatal synaptosomes: pharmacological characterisation. J Neurochem 54:937–945
Reavill C, Stolerman IP (1991) Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br J Pharmacol 99:273–278
Singer G, Wallace M, Hall R (1982) Effects of dopaminergic nucleus accumbens lesions on the aquisition of schedule-induced self-injection of nicotine in the rat. Pharmacol Biochem Behav 17:579–581
Somjet CG, Allen BW, Balestrino M, Aitken P (1987) Pathophysiology of pH and Ca2+ in blood stream and brain. Can J Physiol Pharmacol 65:1078–1085
Westerink BHC, De Vries JB (1988) Characterisation of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantation: methodological aspects. J Neurochem 51:683–687
Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benwell, M.E.M., Balfour, D.J.K. & Lucchi, H.M. Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine. Psychopharmacology 112, 467–474 (1993). https://doi.org/10.1007/BF02244896
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244896